Results 21 to 30 of about 184,721 (306)

Sleep and Antibody Response to Hepatitis B Vaccination [PDF]

SLEEP, 2012
Study Objectives: Experimental evidence links poor sleep with susceptibility to infectious illness; however, it remains to be determined if naturally occurring sleep is associated with immune responses known to play a role in protection against infection. The aim of this study was to determine whether sleep duration, sleep efficiency, and sleep quality,
Prather, Aric A, Hall, Martica, Fury, Jacqueline M, Ross, Diana C, Muldoon, Matthew F, Cohen, Sheldon, Marsland, Anna L   +6 more
openaire   +4 more sources

Hepatitis B testing practices at a tertiary care centre and their associated costs: A retrospective analysis.

PLoS ONE, 2019
BackgroundHepatitis B is a viral infection requiring specific serologic testing to diagnose the stage of the disease. There are many tests which can be ordered in a variety of combinations.
Alexander Lawandi, Matthew P Cheng, Todd C Lee   +2 more
doaj   +1 more source

Evaluation of hepatitis B vaccination status and immune response among clinicians in a tertiary care hospital in South India

Journal of Clinical and Scientific Research, 2019
Background: Hepatitis B virus (HBV) infection remains an important health issue with an estimated 2 billion people worldwide infected with HBV. The risk of contracting HBV by health-care workers (HCWs) is four times greater than that of the general adult
R Jayaprada, N Ramakrishna, B Vasavi, B Venkataramana, K K Sharma   +4 more
doaj   +1 more source

What Level of Hepatitis B Antibody Is Protective? [PDF]

The Journal of Infectious Diseases, 1999
This study assessed the level of vaccine-induced hepatitis B surface antibody that is protective against hepatitis B infection and carriage in The Gambia. Sera from 700 of a cohort of 1041 children vaccinated against hepatitis B in infancy were serially tested for markers of hepatitis B until age 7 years.
A D, Jack, A J, Hall, N, Maine, M, Mendy, H C, Whittle   +4 more
openaire   +2 more sources

Prevalence of Hepatitis B and Hepatitis C Infections in a Tertiary Care Hospital, Telangana, India - Comparison of Pre-Pandemic and COVID-19 Pandemic times

Journal of Pure and Applied Microbiology, 2022
WHO estimates show that 296 million people were living with chronic hepatitis B infection in 2019 with 1.5 million new infections occurring every year and approximately 290 000 people died from hepatitis C, mostly from cirrhosis and hepatocellular ...
C. Roopa, Suryakiran Kamineni, Panthagani Narasimhulu Shilpa, Bheemathati Ranga Rao   +3 more
doaj   +1 more source

Prevalence of Hepatitis B Antigen and Antibody in Prostitutes [PDF]

BMJ, 1974
We investigated the prevalence of hepatitis B antigen (HBAg) and antibody (HBAb) in 293 prostitutes and in 379 pregnant women of similar age and of low socioeconomic level, who served as controls. HBAg was found in 4.4% of prostitutes and 3.4% of controls. The prevalence of HBAb was significantly higher (P
Papaevangelou, G., Trichopoulos, D., Kremastinou, T., Papoutsakis, G.   +3 more
openaire   +3 more sources

Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies

Memorias do Instituto Oswaldo Cruz, 2006
In this report, we examine the adaptability of commercially available serological kits to detect antibodies markers for viral hepatitis in oral fluid samples. We also assessed the prevalence of hepatitis A, B, and C virus-specific antibodies, and related
Luciane A Amado, Livia M Villar, Vanessa S de Paula, Adilson J de Almeida, Ana Maria C Gaspar   +4 more
doaj   +1 more source

Hepatitis B Vaccination in Persons with Isolated Hepatitis B Core Antibodies [PDF]

Clinical Infectious Diseases, 1999
SIR-Silva et al. [1] suggested that in the population they have studied, isolated antibodies to hepatitis B core antigen (anti-HBc) are false-positive results. Their arguments are based on the facts that only five persons among the 133 investigated had hepatitis B virus (HBV) DNA detected in their serum and that most had a primary response to HBV ...
Brian J. McMahon, Alan J. Parkinson
openaire   +3 more sources

Hepatitis B virus antibody prevalence in anaesthetists [PDF]

Canadian Anaesthetists’ Society Journal, 1984
The prevalence of antibodies to hepatitis B virus (anti HBs or anti HBc) was 16.9 per cent in a group of anaesthetists, compared to 3.7 per cent in volunteer blood donors and 5.6 per cent of patients without hepatic infections. Professional risk factors such as treating a hepatitis B patient or working in a hospital laboratory, haemodialysis, an ...
M A, Chernesky, R A, Browne, P, Rondi
openaire   +2 more sources

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source